Medicare Enrolled

Dr. Craig Zalvan, MD

Otolaryngology · Tarrytown, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
200 WHITE PLAINS RD STE 201, Tarrytown, NY 10591
9146313053
In practice since 2006 (19 years)
NPI: 1790891117 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zalvan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zalvan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zalvan

Dr. Craig Zalvan is an otolaryngology specialist in Tarrytown, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zalvan performed 3,551 Medicare services across 2,884 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zalvan received a total of $65,983 from 36 pharmaceutical and/or device companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in otolaryngology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zalvan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 7% volume in NY $65,983 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,551
Medicare services
Top 7% in NY for otolaryngology
2,884
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~187 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
883 $81 $217
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
579 $120 $225
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
385 $41 $281
Vocal cord movement assessment with endoscope
This procedure uses an endoscope to examine the movement of the vocal cords. It allows for the visual assessment of how the vocal cord flaps function.
373 $184 $828
Nasal endoscopy
A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages.
238 $173 $766
Swallowing evaluation using endoscope
This procedure involves evaluating, recording, and interpreting the swallowing process by using an endoscope to visualize the throat and esophagus.
188 $34 $222
Swallowing evaluation using an endoscope
This procedure involves using an endoscope to visually evaluate and record the swallowing process.
186 $179 $932
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
163 $157 $360
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
154 $97 $200
Impacted earwax removal by physician
Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing.
130 $47 $109
Flexible laryngoscopy
A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx.
75 $113 $290
Esophageal biopsy via flexible endoscope through nose
A procedure to collect tissue samples from the esophagus using a flexible tube inserted through the nose. The samples are examined to check for abnormalities or disease.
48 $194 $939
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $51 $130
Esophageal function monitoring via nasal tube
This procedure involves monitoring and recording the function of the esophagus using a tube inserted through the nose.
25 $182 $1,021
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
24 $48 $77
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $78 $141
Voice box injection to augment voice
A substance is injected into the voice box using an endoscope to augment or improve voice function.
21 $947 $6,306
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
14 $18 $52
Nasal endoscopy of esophagus
A diagnostic exam of the esophagus using a flexible endoscope inserted through the nose.
13 $136 $843
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$65,983
Total received (2018-2024)
Avg $9,426/year across 7 years
Top 2% in NY for otolaryngology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
227
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$57,412 (87.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,455 (6.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,116 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,347
2023
$1,741
2022
$8,860
2021
$7,036
2020
$1,053
2019
$11,421
2018
$31,525

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merz Pharmaceuticals, LLC
$2,400
PENTAX of America, Inc.
$1,420
Optinose US, Inc.
$137
Hikma Pharmaceuticals USA
$70
CSL Behring
$61
Pharming Healthcare, Inc.
$50
Integra LifeSciences Corporation
$46
Medtronic, Inc.
$45
Neurent Medical Limited
$31
Genentech USA, Inc.
$24
Phathom Pharmaceuticals, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
Smith+Nephew, Inc.
$16
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
PENTAX of America, Inc.
$46,696
Merz North America, Inc.
$6,000
Merck Sharp & Dohme Corporation
$4,455
Merz Pharmaceuticals, LLC
$3,600
Lucid Diagnostics Inc.
$805
MERZ NORTH AMERICA, INC.
$600
Optinose US, Inc.
$440
Takeda Pharmaceuticals U.S.A., Inc.
$336
OptiNose US, Inc.
$334
GENZYME CORPORATION
$321
Pharming Healthcare, Inc.
$277
BioCryst US Sales Co., LLC
$257
Covidien LP
$210
CSL Behring
$198
Integra LifeSciences Corporation
$169
Novartis Pharmaceuticals Corporation
$162
Medtronic, Inc.
$141
Intersect ENT, Inc.
$139
Regeneron Healthcare Solutions, Inc.
$133
Hikma Pharmaceuticals USA
$128
AstraZeneca Pharmaceuticals LP
$100
GlaxoSmithKline, LLC.
$89
BioCryst Pharmaceuticals, Inc.
$44
Medtronic USA, Inc.
$43
Merck Sharp & Dohme LLC
$41
Genentech USA, Inc.
$38
Stryker Corporation
$32
Neurent Medical Limited
$31
Incyte Corporation
$28
kaleo, Inc.
$27
Phathom Pharmaceuticals, Inc.
$24
PFIZER INC.
$18
Cook Medical LLC
$17
ALK-Abello, Inc
$17
Smith+Nephew, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$16
Top 3 companies account for 86.6% of all-time payments
Associated products mentioned in payments ›
ACCLARENT AERA · AUVI-Q · CUVITRU · Cook Medical Biodesign · DEFINA · DUPIXENT · ESOCHECK CCD CELL COLLECTION DEVICE · EUCRISA · FASENRA · HALO · HYQVIA · Haegarda · Hizentra · INSTRUMENTS-ENT · LIBTAYO · Manometry · NEUROMARK Device · NUCALA · OPZELURA · ORLADEYO · Odactra · Orladeyo · Otovel · PROLAYRN · PROPEL · RUCONEST · Ryaltris · S7 · SINUVA · Signia · TAKHZYRO · TRELEGY ELLIPTA · VOQUEZNA · XOLAIR · XPRESS ENT DILATION SYSTEM · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for otolaryngology in NY.

Looking for an otolaryngology specialist in Tarrytown?
Compare otolaryngologists in the Tarrytown area by procedure volume, costs, and industry payment transparency.
Browse otolaryngologists nearby

Geographic Context

Otolaryngologists within 10 mi
402
Per 100K population
40.3
County median income
$118,411
Nearest hospital
PHELPS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zalvan is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with consulting-driven industry engagement in the top 2% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zalvan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Zalvan performed 883 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zalvan receive payments from pharmaceutical companies?
Yes. Dr. Zalvan received a total of $65,983 from 36 companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zalvan's costs compare to other otolaryngologists in Tarrytown?
Dr. Zalvan's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zalvan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →